Our objective was to assess the feasibility of 18F-FDG PET/CT for noninvasive monitoring of
treatment response after allogeneic stem cell transplantation (SCT) for myelofibrosis …

Myelofibrosis is a rare hematopoietic stem cell neoplasm leading to marked bone marrow
fibrosis and ineffective hematopoiesis. We report a case highlighting the potential role of 18 …

Purpose Myelofibrosis is a haematopoietic stem cell neoplasm characterized by bone
marrow inflammation, reactive marrow fibrosis and extramedullary haematopoiesis. The aim …

An emerging noninvasive approach to assess tissue proliferation uses the PET tracer 3′-
deoxy-3′-18F-fluorothymidine (18F-FLT). To evaluate the diagnostic value of this technique …

Objective This study retrospectively analyzed clinical outcomes of allogeneic hematopoietic
stem cell transplantation (allo-HSCT) for myelofibrosis (MF) in a single institution. Methods …

Recent studies have advocated the utility of fluorine-18 fluorodeoxyglucose-positron
emission tomography (18) F-FDG-PET imaging in evaluation of various hematological …

Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative
option for patients with myelofibrosis (MF). Bone marrow (BM) morphologic evaluation of …

Myelofibrosis is a rare clonal hematopoietic stem cell disorder characterized by chronic
myeloproliferation, atypical megakaryocytic hyperplasia, and potential leukemic …

Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients,
but relapse is a major cause of treatment failure. We investigated the effect of donor …

538 Objectives Bone marrow aspiration & trephine biopsy (BMAT) assesses only a
proportion small of total bone marrow (BM) and cannot define global BM activity or extra …